Metagenomi Therapeutics (MGX) Return on Sales (2023 - 2026)
Metagenomi Therapeutics (MGX) posted quarterly Return on Sales of 0.18% for Q1 2026, down 12.0% year-over-year from 0.21% in Q1 2025, and down 1653.1% quarter-over-quarter from 0.01% in Q4 2025.
Metagenomi Therapeutics (MGX) Return on Sales (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Return on Sales for 4 consecutive years, with 0.18% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Sales fell 12.0% year-over-year to 0.18%; the TTM figure through Mar 2026 stood at 0.03% (down 1.0% YoY), while the FY2025 annual figure was 0.03%, down 1.0% from the prior year.
- Return on Sales slipped to 0.18% in Q1 2026 per MGX's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Sales topped out at 0.01% in Q2 2024 and bottomed at 0.18% in Q1 2026.
- Historically, Return on Sales has averaged 0.03% across 4 years, with a median of 0.02% in 2024.
- Annual changes were most pronounced in 2024 — Return on Sales rose 1 bps — and 2026, when it decreased 12 bps.
- Metagenomi Therapeutics' Return on Sales stood at 0.02% in 2023, then sank by 56 bps to 0.02% in 2024, then jumped by 57 bps to 0.01% in 2025, then tumbled by 1653 bps to 0.18% in 2026.
- Business Quant data shows MGX's Return on Sales at 0.18% in Q1 2026, 0.01% in Q4 2025, and 0.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.08 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.11 Bn | 78.11 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 56.09 Bn | 50.96 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.49 Bn | 26.32 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 0.00% |
| 10 | Metagenomi Therapeutics | 46.51 Mn | 46.51 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.18% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.06% |
| Dec 31, 2024 | -0.02% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |